Brain and Behavior (Jul 2022)

No add‐on effect of tDCS on fatigue and depression in chronic stroke patients: A randomized sham‐controlled trial combining tDCS with computerized cognitive training

  • Kristine M. Ulrichsen,
  • Knut K. Kolskår,
  • Geneviève Richard,
  • Mads Lund Pedersen,
  • Dag Alnæs,
  • Erlend S. Dørum,
  • Anne‐Marthe Sanders,
  • Sveinung Tornås,
  • Luigi A. Maglanoc,
  • Andreas Engvig,
  • Hege Ihle‐Hansen,
  • Jan E. Nordvik,
  • Lars T. Westlye

DOI
https://doi.org/10.1002/brb3.2643
Journal volume & issue
Vol. 12, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract Background Fatigue and emotional distress rank high among self‐reported unmet needs in life after stroke. Transcranial direct current stimulation (tDCS) may have the potential to alleviate these symptoms for some patients, but the acceptability and effects for chronic stroke survivors need to be explored in randomized controlled trials. Methods Using a randomized sham‐controlled parallel design, we evaluated whether six sessions of 1 mA tDCS (anodal over F3, cathodal over O2) combined with computerized cognitive training reduced self‐reported symptoms of fatigue and depression. Among the 74 chronic stroke patients enrolled at baseline, 54 patients completed the intervention. Measures of fatigue and depression were collected at five time points spanning a 2 months period. Results While symptoms of fatigue and depression were reduced during the course of the intervention, Bayesian analyses provided evidence for no added beneficial effect of tDCS. Less severe baseline symptoms were associated with higher performance improvement in select cognitive tasks, and study withdrawal was higher in patients with more fatigue and younger age. Time‐resolved symptom analyses by a network approach suggested higher centrality of fatigue items (except item 1 and 2) than depression items. Conclusion The results reveal no add‐on effect of tDCS on fatigue or depression but support the notion of fatigue as a relevant clinical symptom with possible implications for treatment adherence and response.

Keywords